For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...

Knowing what to ask your doctor about your CLL treatment can help you feel more comfortable with your diagnosis and know what to expect for the future. There are many treatment options ...

Investigators found that lipid metabolism disruptions spark T-cell dysfunction in patients with chronic lymphocytic leukemia.

Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune ...

Several biological mechanisms may explain this observed association. CLL is characterized by chronic low-grade inflammation, which can promote endothelial dysfunction, vasoconstriction, and ...

Different chronic lymphocytic leukemia (CLL) treatments and their side effects can be dehydrating. You can take steps to reduce the risk of dehydration. If you’re not able to keep up with your ...

Co-Located Cell Types Help Drive Aggressive Brain Tumors Feb. 7, 2025 — A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth ...

Read more about therapies for CLL Minimal residual disease negativity ... neutropenia, infections, sepsis, pneumonia, tumor lysis syndrome, or infusion-related reactions. However, venetoclax-based ...

ICP-248 exerts anti-tumor activity by selectively inhibiting ... will provide deeper remission for treatment-naïve CLL/SLL patients without drug-resistant mutations, bringing hope of clinical ...